iMouse
Berlin, Germany
The iMouse GmbH is a Berlin-based deep-tech company transforming preclinical research through AI-driven behavioral phenotyping. Its platform converts continuous in vivo monitoring into standardized digital biomarkers, enabling earlier, data-driven decisions in drug development. By replacing subjective observation methods, iMouse improves reproducibility, translational relevance, and scalability across pharma, CROs, and academia.
Company Info
- Founded
- 2025
- Website
- imouse.info/
Only accessible to MedStartr community members.
Join nowWhat do you think of iMouse?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.